• 1
    Statistics Canada. Aboriginal population profile, 2006 census: catalogue no. 92-594-XWE. Ottawa: Statistics Canada; 2007.
  • 2
    Ferucci ED, Templin DW, Lanier AP. Rheumatoid arthritis in American Indians and Alaska natives: a review of the literature. Semin Arthritis Rheum 2005; 34: 6627.
  • 3
    Barnabe C, Elias B, Bartlett J, Roos L, Peschken C. Arthritis in Aboriginal Manitobans: evidence for a high burden of disease. J Rheumatol 2008; 35: 114550.
  • 4
    Acers TE, Acers-Warn A. Incidence patterns of immunogenetic diseases in the North American Indians. J Okla State Med Assoc 1994; 87: 30914.
  • 5
    Peschken CA, Esdaile JM. Rheumatic diseases in North America's Indigenous peoples. Semin Arthritis Rheum 1999; 28: 36891.
  • 6
    Public Health Surveillance and Environmental Health Branch, Public Health Division, Alberta Health and Wellness. Fort Chipewyan health data analysis. Edmonton (Canada): Alberta Health and Wellness; 2006.
  • 7
    Atkins C, Reuffel L, Roddy J, Platts M, Robinson H, Ward R. Rheumatic disease in the Nuu-Chah-Nulth Native Indians of the Pacific Northwest. J Rheumatol 1988; 15: 68490.
  • 8
    Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 2000; 27: 188491.
  • 9
    Boyer GS, Templin DW, Lanier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1991; 18: 147784.
  • 10
    Morton RO, Gershwin ME, Brady C, Steinberg AD. The incidence of systemic lupus erythematosus in North American Indians. J Rheumatol 1976; 3: 18690.
  • 11
    Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma: association with an Amerindian HLA haplotype. Arthritis Rheum 1996; 39: 136270.
  • 12
    Bernatsky S, Lix L, Hanly JG, Hudson M, Badley E, Peschken C, et al. Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int 2011; 31: 54954.
  • 13
    Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE. A population-based assessment of systemic lupus erythematosus incidence and prevalence: results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 2007; 46: 18148.
  • 14
    Bernatsky S, Joseph L, Pineau CA, Belisle P, Boivin JF, Banerjee D, et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 2009; 68: 11926.
  • 15
    Bernatsky S, Joseph L, Pineau CA, Belisle P, Hudson M, Clarke AE. Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Rheum 2009; 61: 4004.
  • 16
    Newbold KB. Aboriginal physician use in Canada: location, orientation and identity. Health Economics 1997; 6: 197207.
  • 17
    Diverty B, Perez C. The health of northern residents. Health Reports 1998; 9: 4955.
  • 18
    Gao S, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, et al. Access to health care among status Aboriginal people with chronic kidney disease. CMAJ 2008; 179: 100712.
  • 19
    Government of Alberta, Alberta Health and Wellness. Comparison of Alberta population counts between the AHCIP registry and the 2006 census. Edmonton (Canada); 2009.
  • 20
    Statistics Canada. Geographic units: census metropolitan area (CMA) and census agglomeration (CA). Ottawa: Statistics Canada; 2002.
  • 21
    Health surveillance, Alberta Health and Wellness. First Nations health services study technical documentation. Edmonton (Canada); 2004.
  • 22
    Cardinal JC, Schopflocher DP, Svenson LW, Morrison KB, Laing L. First Nations in Alberta: a focus on health service use. Edmonton (Canada): Alberta Health and Wellness; 2004.
  • 23
    Gao S, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, et al. Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol 2007; 18: 29539.
  • 24
    Dendukuri N, Joseph L. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics 2001; 57: 15867.
  • 25
    Ward MM. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health (Larchmt) 2004; 13: 7138.
  • 26
    Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 224655.
  • 27
    Robinson D Jr, Eisenberg D, Nietert PJ, Doyle M, Bala M, Paramore C, et al. Systemic sclerosis prevalence and comorbidities in the US, 2001-2002. Curr Med Res Opin 2008; 24: 115766.
  • 28
    Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 1999; 42: 4650.
  • 29
    Interactive health data application. 2011. URL:
  • 30
    Parks CG, Cooper GS, Nylander-French LA, Sanderson WT, Dement JM, Cohen PL, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case–control study in the southeastern United States. Arthritis Rheum 2002; 46: 184050.
  • 31
    Parks CG, Cooper GS, Dooley MA, Park MM, Treadwell EL, Gilkeson GS. Childhood agricultural and adult occupational exposures to organic dusts in a population-based case-control study of systemic lupus erythematosus. Lupus 2008; 17: 7119.
  • 32
    Lacaille D, Lix L, Bernatsky S, O'Donnell S, Bombardier C. Consensus statements concerning the use of administrative data in rheumatology research and surveillance [abstract]. Arthritis Rheum 2011; 63 Suppl: S733.